Bixiye
QP26-22 Provider Directory Validation (PDV) Tool
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Natiijooyinka Raadinta
Soo bandhiga 1801 - 1810 ee natiijooyinka 3688
Bixiye
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
P20-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective June 6, 2022
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2022
Bixiye
P21-22 Medical Drug Management Update – Infliximab Prior Authorization and Preferred Product Expansion to Include Unbranded Infliximab
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2022
Bixiye
P22-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2022
Bixiye
Opzelura™ (ruxolitinib) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Bixiye
Zeposia® (ozanimod) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
P17-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2022
Bixiye
P18-22 Non-Covered Procedure Codes for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2022